#66: TheMachine: DEPO Stock News : Depomed Completes Enrollment of Phase 3 Clinical Program of DM-1796 in Post-Herpetic Neuralgia
Depomed, Inc. (NASDAQ:DEPO) announced today that it has completed
... |
June 15, 2009
01:28:16 AM |
#65: TheMachine: DEPO News : Covidien and Depomed Announce License Agreement
Covidien (NYSE:COV) (BSX:COV) and Depomed, Inc. (NASDAQ:DEPO) today
... |
December 24, 2008
12:51:42 AM |
#64: TheMachine: Depomed Initiates Phase 3 Program in Menopausal Hot Flashes
Depomed, Inc. (NASDAQ:DEPO) announced today the enrollment and dosing... |
September 20, 2008
01:12:53 AM |
#63: TheMachine: Depomed to Present at the BIO CEO & Investor Conference
Depomed, Inc. (NASDAQ:DEPO) today announced that president and chief... |
February 5, 2008
08:57:51 AM |
#62: TheMachine: Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Depomed, Inc. (NASDAQ:DEPO) announced today that it has received
... |
January 29, 2008
02:21:33 AM |
#61: Stock News Bot: Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Depomed, Inc. (NASDAQ:DEPO) announced today that it has received
approval... |
January 16, 2008
09:31:34 AM |
#60: Stock News Bot: DEPO News Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
April 2, 2007
07:00:00 AM |
#59: Stock News Bot: DEPO News Depomed Appoints David Zenoff to Board of Directors
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
March 23, 2007
04:00:00 AM |
#58: Stock News Bot: DEPO News Depomed Reports 2006 Year End Financial Results
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
March 14, 2007
01:00:00 PM |
#57: Stock News Bot: DEPO News Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today... |
March 12, 2007
04:00:00 AM |
#56: Stock News Bot: DEPO News Depomed Completes Patient Enrollment in Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
March 8, 2007
04:00:00 AM |
#55: Stock News Bot: DEPO News Depomed to Announce Fourth Quarter and Year End 2006 Financial Results on Wednesday, March 14
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
February 28, 2007
04:00:00 AM |
#54: Stock News Bot: DEPO News Depomed to Present at the Oppenheimer Pain Management Conference
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced... |
February 27, 2007
04:00:00 AM |
#53: Stock News Bot: DEPO News Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
MENLO PARK, Calif. & EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Depomed, Inc.... |
December 21, 2006
02:00:00 PM |
#52: Stock News Bot: DEPO News Depomed Announces Sweeping Interim Victory in Litigation against Ivax
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced a... |
December 20, 2006
01:04:00 PM |
